Rotallas, Rufa May M.
HRN: 22-43-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2023
CEFTRIAXONE 1G (VIAL)
09/21/2023
09/28/2023
IV
2g
IV
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Overall appropriateness: Yes